These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17564576)

  • 1. [Leukopenia in kidney transplantation resulting from the interaction between mycophenolate mofetil and valganciclovir].
    Izquierdo MJ; Rodrigo E; de Cos MA; Arias M
    Nefrologia; 2007; 27(2):232-3. PubMed ID: 17564576
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukopenia in kidney transplant patients with the association of valganciclovir and mycophenolate mofetil.
    Brum S; Nolasco F; Sousa J; Ferreira A; Possante M; Pinto JR; Barroso E; Santos JR
    Transplant Proc; 2008 Apr; 40(3):752-4. PubMed ID: 18455007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valganciclovir-induced leukopenia in liver transplant recipients: influence of concomitant use of mycophenolate mofetil.
    Molina Perez E; Fernández Castroagudín J; Seijo Ríos S; Mera Calviño J; Tomé Martínez de Rituerto S; Otero Antón E; Bustamante Montalvo M; Varo Perez E
    Transplant Proc; 2009 Apr; 41(3):1047-9. PubMed ID: 19376423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected rate of severe leucopenia with the association of mycophenolate mofetil and valganciclovir in kidney transplant recipients.
    Rerolle JP; Szelag JC; Le Meur Y
    Nephrol Dial Transplant; 2007 Feb; 22(2):671-2. PubMed ID: 16980323
    [No Abstract]   [Full Text] [Related]  

  • 5. Sirolimus: a switch option for mycophenolate mofetil-induced leukopenia in renal transplant recipients.
    Shin BC; Chung JH; Kim HL
    Transplant Proc; 2013 Oct; 45(8):2968-9. PubMed ID: 24157014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycophenolate mofetil--a new immunosuppressant for organ transplantation.
    Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993
    [No Abstract]   [Full Text] [Related]  

  • 7. Mycophenolate mofetil and oral ulcerations.
    Apostolou T; Tsagalis G; Koutroubas G; Hadjiconstantinou V; Drakopoulos S
    Transplantation; 2004 Jun; 77(12):1911-2. PubMed ID: 15223919
    [No Abstract]   [Full Text] [Related]  

  • 8. Cytomegalovirus colitis and viremia from mycophenolate mofetil monotherapy in birdshot chorioretinopathy.
    Pantanelli SM; Khalifa YM
    Ocul Immunol Inflamm; 2011 Dec; 19(6):450-2. PubMed ID: 22106917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of mycophenolate mofetil and intravenous ganciclovir alone and in combination in renal transplant recipients.
    Wolfe EJ; Mathur V; Tomlanovich S; Jung D; Wong R; Griffy K; Aweeka FT
    Pharmacotherapy; 1997; 17(3):591-8. PubMed ID: 9165564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neutropenia suggesting an interaction between valacyclovir and mycophenolate mofetil.
    Royer B; Zanetta G; Bérard M; Davani S; Tanter Y; Rifle G; Kantelip JP
    Clin Transplant; 2003 Apr; 17(2):158-61. PubMed ID: 12709084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil.
    Lipsky JJ
    Lancet; 1996 Nov; 348(9038):1357-9. PubMed ID: 8918281
    [No Abstract]   [Full Text] [Related]  

  • 12. CMV in kidney transplants in the tacrolimus-mycophenolate era.
    Cailhier JF; Boucher A; Béliveau C; Poirier L; Delorme J; Weiss K; Laverdière M; Hébert MJ; Pichette V; Dandavino R
    Transplant Proc; 2001; 33(1-2):1196-7. PubMed ID: 11267255
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mycophenolate mofetil].
    Abramowicz D; Broeders N; Wissing M; Sternon J
    Rev Med Brux; 1998 Jun; 19(3):139-43. PubMed ID: 9697397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of leukopenia and cytomegalovirus disease in kidney transplants treated with mycophenolate mofetil combined with low cyclosporine and steroid doses.
    Moreso F; Serón D; Morales JM; Cruzado JM; Gil-Vernet S; Pérez JL; Fulladosa X; Andrés A; Grinyó JM
    Clin Transplant; 1998 Jun; 12(3):198-205. PubMed ID: 9642510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-life-threatening leukopenia in a renal transplant recipient with acute overdose of mycophenolate mofetil.
    Wu SW; Chang HR; Lai YR; Lian JD
    Transplant Proc; 2008 Dec; 40(10):3770-1. PubMed ID: 19100486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycophenolate mofetil in pregnancy after renal transplantation: a case of major fetal malformations.
    Le Ray C; Coulomb A; Elefant E; Frydman R; Audibert F
    Obstet Gynecol; 2004 May; 103(5 Pt 2):1091-4. PubMed ID: 15121619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congenital malformations with low-dose mycophenolate mofetil after kidney transplantation.
    Koshy AN; Strong D; Earles G; Fassett RG
    Nephrology (Carlton); 2010 Feb; 15(1):133-5. PubMed ID: 20377782
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycophenolate mofetil toxicity in an anorexic kidney transplant patient treated with sulphinpirazone.
    Catalano C; Fabbian F; Bordin V; Di Landro D
    Nephrol Dial Transplant; 1997 Nov; 12(11):2467-8. PubMed ID: 9394357
    [No Abstract]   [Full Text] [Related]  

  • 19. Mycophenolate mofetil and bronchiectasis in pediatric transplant patients.
    Merkus PJ; Pijnenburg M; Cransberg K
    Transplantation; 2006 Nov; 82(10):1386. PubMed ID: 17130793
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic determinants of mycophenolate-related anemia and leukopenia after transplantation.
    Jacobson PA; Schladt D; Oetting WS; Leduc R; Guan W; Matas AJ; Lamba V; Mannon RB; Julian BA; Israni A;
    Transplantation; 2011 Feb; 91(3):309-16. PubMed ID: 21107304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.